New Delhi: Delhi has run out of its Covaxin stock just one week after launching the vaccination drive for the age group of 18 to 44 years. The AAP government in Delhi said it has run out of Covaxin in all its vaccination centres.
Deputy chief minister Manish Sisodia said that the makers of Covaxin, Hyderabad-based Bharat Biotech, has refused to supply vaccine doses to the national capital under the guidelines received from the Central government.
Sisodia also accused the Centre of vaccine mismanagement and controlling the supply of Covid shots, adding that the Delhi government had placed orders for 67 lakh doses each of both vaccines – Covaxin and Covishied.
On Delhi government’s order for procuring additional Covaxin doses placed on May 7, Bharat Biotech replied, “There has been unprecedented demand for our vaccine and in spite of increasing production every month, we are unable to keep up with the demand.
“Further, we are making dispatches as per the directives of the concerned government officials. We therefore sincerely regret that we cannot make any additional supply as required by you (Delhi government).
Even as Centre has earlier said that states can directly procure vaccines from the manufacturers, the deputy chief minister said that the government has been controlling the vaccine supply.
The Delhi government had started the inoculation drive for people in the 18-44 years age group, who comprise more than half of the city’s population, at all the 301 vaccination centres on May 4.
Earlier, Delhi CM Arvind Kejriwal had said that with smooth supply of vaccination doses, Delhi can inoculate its complete population in 2-3 months.
The Delhi government began the third phase of vaccination drive for people in the 18-44 years age group on May 4 at all the 301 vaccination centres.
As per the Delhi government, around 92 lakh people are eligible to receive the jab in the 18-44 age bracket.